Advertisement for orthosearch.org.uk
Results 1 - 20 of 35
Results per page:
The Bone & Joint Journal
Vol. 105-B, Issue 8 | Pages 837 - 838
1 Aug 2023
Kelly M McNally SA Dhesi JK


Bone & Joint Research
Vol. 11, Issue 1 | Pages 29 - 31
20 Jan 2022
Ma M Tan Z Li W Zhang H Liu Y Yue C


Bone & Joint Research
Vol. 10, Issue 9 | Pages 571 - 573
2 Sep 2021
Beverly MC Murray DW


Bone & Joint Open
Vol. 5, Issue 9 | Pages 766 - 767
13 Sep 2024
Parker MJ


The Bone & Joint Journal
Vol. 106-B, Issue 2 | Pages 111 - 113
1 Feb 2024
Howard A Thomas GER Perry DC


Bone & Joint 360
Vol. 13, Issue 2 | Pages 5 - 6
1 Apr 2024
Ollivere B


The Bone & Joint Journal
Vol. 105-B, Issue 6 | Pages 590 - 592
1 Jun 2023
Manktelow ARJ Mitchell P Haddad FS

Cite this article: Bone Joint J 2023;105-B(6):590–592.


The Bone & Joint Journal
Vol. 104-B, Issue 12 | Pages 1281 - 1283
1 Dec 2022
Azizpour K Birch NC Peul WC


Bone & Joint 360
Vol. 12, Issue 2 | Pages 3 - 4
1 Apr 2023
Rocos B Ruffles K


Bone & Joint Research
Vol. 12, Issue 1 | Pages 5 - 8
1 Jan 2023
Im G

Cite this article: Bone Joint Res 2023;12(1):5–8.


Bone & Joint Research
Vol. 11, Issue 1 | Pages 26 - 28
20 Jan 2022
Ma M Tan Z Li W Zhang H Liu Y Yue C


The Bone & Joint Journal
Vol. 104-B, Issue 3 | Pages 309 - 310
1 Mar 2022
Haddad FS


The Bone & Joint Journal
Vol. 103-B, Issue 11 | Pages 1642 - 1645
1 Nov 2021
Kayani B Giebaly D Haddad FS


The Bone & Joint Journal
Vol. 103-B, Issue 10 | Pages 1553 - 1554
1 Oct 2021
Haddad FS


Bone & Joint Research
Vol. 10, Issue 6 | Pages 348 - 350
1 Jun 2021
Skinner JA Sabah SA Hart AJ


The Bone & Joint Journal
Vol. 103-B, Issue 5 | Pages 805 - 806
1 May 2021
Magan AA Haddad FS



The Bone & Joint Journal
Vol. 103-B, Issue 4 | Pages 597 - 599
1 Apr 2021
Kader DF Oussedik S Kader N Haddad FS


Bone & Joint Research
Vol. 10, Issue 2 | Pages 134 - 136
1 Feb 2021
Im G

The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells, exosomes, and genes is summarized along with the author’s perspectives. Despite a tremendous interest, so far there is very little evidence proving the efficacy of this modality for clinical application. As symptomatic relief is not sufficient to justify the high cost associated with regenerative medicine, definitive structural improvement that would last for years or decades and obviate or delay the need for joint arthroplasty is essential for regenerative medicine to retain a place among OA treatment methods.

Cite this article: Bone Joint Res 2021;10(2):134–136.


Bone & Joint Research
Vol. 9, Issue 4 | Pages 200 - 201
1 Apr 2020
Simpson AHRW Dall G Haas JG